The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor

被引:38
作者
Abbracchio, MP
Burnstock, G
Boeynaems, JM
Barnard, EA
Boyer, JL
Kennedy, C
Miras-Portugal, MT
King, BF
Gachet, C
Jacobson, KA
Weisman, GA
机构
[1] Royal Free & Unvi Coll Med Sch Sch, Auton Neurosci Inst, London NW3 2PF, England
[2] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy
[3] Free Univ Brussels, IRIBHM, B-1070 Brussels, Belgium
[4] Free Univ Brussels, Erasme Hosp, Dept Med Chem, B-1070 Brussels, Belgium
[5] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England
[6] Inspire Pharmaceut Inc, Mol Pharmacol, Durham, NC 27703 USA
[7] Univ Strathclyde, Dept Physiol & Pharmacol, Glasgow G4 0NR, Lanark, Scotland
[8] Univ Complutense Madrid, Dept Bioquim, E-28040 Madrid, Spain
[9] EFS Alsace, INSERM, U311, F-67065 Strasbourg, France
[10] NIDDK, Bioorgan Chem Lab, Bethesda, MD 20892 USA
[11] Univ Missouri, Dept Biochem, Columbia, MO 65212 USA
关键词
D O I
10.1016/j.tips.2004.10.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The P2Y receptor family currently encompasses eight members (P2Y(1,2,4,6,11,12,13,14) receptors) that are activated by extracellular adenine and/or uracil nucleotides, or, in the case of the P2Y(14) receptor, by sugar-nucleotides, and are each characterized by the typical seven-transmembrane domain topology of G-protein-coupled receptors (GPCRs) [1]. For several years, it has been known that a series of 'orphan' GPCRs (i.e. cloned receptors available in the public database for which a natural ligand has not yet been identified) share significant sequence identity with the eight genuine P2Y receptors [1,2] and thus putatively represent novel members of the P2Y receptor family.
引用
收藏
页码:8 / 9
页数:2
相关论文
共 8 条
[1]   Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family [J].
Abbracchio, MP ;
Boeynaems, JM ;
Barnard, EA ;
Boyer, JL ;
Kennedy, C ;
Miras-Portugal, MT ;
King, BF ;
Gachet, C ;
Jacobson, KA ;
Weisman, GA ;
Burnstock, G .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) :52-55
[2]   P2Y receptors: New subtypes, new functions [J].
Boeynaems, JM ;
Wilkin, F ;
Marteau, F ;
Duhant, X ;
Savi, P ;
Gonzalez, NS ;
Robaye, B ;
Communi, D .
DRUG DEVELOPMENT RESEARCH, 2003, 59 (01) :30-35
[3]  
GONZALES NS, IN PRESS PURINERGIC
[4]   Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors [J].
He, WH ;
Miao, FJP ;
Lin, DCH ;
Schwandner, RT ;
Wang, ZL ;
Gao, JH ;
Chen, JL ;
Tian, H ;
Ling, L .
NATURE, 2004, 429 (6988) :188-193
[5]   Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine [J].
Inbe, H ;
Watanabe, S ;
Miyawaki, M ;
Tanabe, E ;
Encinas, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) :19790-19799
[6]  
QI AD, IN PRESS PURINERGIC
[7]   PR99, a new G protein-coupled receptor with homology to a new subgroup of nucleotide receptors [J].
Wittenberger, T ;
Hellebrand, S ;
Munck, A ;
Kreienkamp, HJ ;
Schaller, HC ;
Hampe, W .
BMC GENOMICS, 2002, 3 (1)
[8]   Heteromeric association creates a P2Y-like adenosine receptor [J].
Yoshioka, K ;
Saitoh, O ;
Nakata, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) :7617-7622